Back to News
Market Impact: 0.4

Micron completes acquisition of PSMC facility in Taiwan

MUWFC
M&A & RestructuringTechnology & InnovationCompany FundamentalsCorporate Guidance & OutlookCorporate EarningsAnalyst EstimatesAnalyst InsightsTrade Policy & Supply Chain
Micron completes acquisition of PSMC facility in Taiwan

Micron completed acquisition of Powerchip’s P5 site in Tongluo, adding 300,000 sq ft of 300mm cleanroom capacity and planning an additional ~270,000 sq ft by end of fiscal 2026; meaningful product shipments are expected in fiscal 2028 and Micron’s market cap is $479.6B. The company reports solid fundamentals (current ratio 2.46, moderate debt) and analysts remain bullish—Mizuho forecasts May-quarter revenue $25B / EPS $11.13 and Aug-quarter $27.2B / EPS $12.25, while Wedbush, Wolfe and Wells Fargo have lifted price targets (to $500/$500/$470); InvestingPro notes the stock is currently overvalued.

Analysis

Micron’s incremental capacity push is a lever that changes where value accrues in the memory chain: near-term P&L upside is concentrated in IDMs that can convert wafer starts to high-value HBM product for hyperscalers, while equipment and materials vendors capture a more durable multi-year stream of orders. Expect equipment orderbooks to show a lead/lag: bookings spike before revenue, so earnings beats at equipment names can precede any durable improvement in memory pricing by 6–18 months. The two principal risks are demand-side digestion and competitive capex response. If hyperscaler inventory normalizes or new entrants accelerate HBM builds, price volatility could compress DRAM/ HBM ASPs quickly; conversely, export controls or logistics disruption out of Taiwan would truncate the intended capacity benefit and reroute premium pricing to onshore alternatives. Short-term earnings catalysts to watch are customer inventory disclosures over the next 2 quarters and memory spot-price indices monthly; medium-term (12–36 months) catalysts are competitor capex announcements and equipment OEM orderbacklogs. Consensus appears to be pricing in linear revenue leverage without sufficiently stress-testing margin dilution when new wafer starts hit the market. That creates an asymmetric outcome: equity upside if AI-driven HBM demand sustains, but disproportionate downside if supply growth outpaces demand — a 20–35% EPS shave from ASP erosion could easily translate into 25–40% multiple compression for the sector. For portfolio construction, tilt toward instruments that capture equipment/orderbook exposure while limiting naked exposure to cyclical memory ASP moves.